NCT06181760View on ClinicalTrials.gov

A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

February 13, 2024

Study Completion Date

February 13, 2024

Conditions
Safety and Tolerability
Interventions
DRUG

Fenretinide

Ascending single doses of oral fenretinide

DRUG

Placebo

Single oral dose of matching placebo capsules

Trial Locations (1)

2031

Island Site 01, Randwick

Sponsors

Collaborators (1)

Beyond Drug Development
All Listed Sponsors
collaborator

Beyond Drug Development

UNKNOWN

lead

Island Pharmaceuticals

INDUSTRY

NCT06181760 - A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers | Biotech Hunter | Biotech Hunter